Category: Pharmaceutical Research

Learn how FDA Import Alerts block non-compliant drug manufacturers, focusing on the 2025 GLP-1 crackdown, Green List requirements, and strategies to avoid costly shipment detentions.

Discover which manufacturing changes trigger FDA re-evaluation for generic drugs. Learn about PAS, CBE, and Annual Report supplements, review timelines, and strategies to navigate GDUFA III requirements efficiently.

Compare in vivo and in vitro bioequivalence testing. Learn when to use human trials versus lab methods, the role of biowaivers, and FDA standards for generic drugs.

Learn how population pharmacokinetics (PopPK) uses sparse clinical data and nonlinear modeling to prove drug equivalence, especially in diverse or high-risk patient groups.